BRPI0516253A - vacinas caninas multivalentes contra leptospira bratislava e outros patógenos - Google Patents

vacinas caninas multivalentes contra leptospira bratislava e outros patógenos

Info

Publication number
BRPI0516253A
BRPI0516253A BRPI0516253-0A BRPI0516253A BRPI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A
Authority
BR
Brazil
Prior art keywords
canine
leptospira
caused
bratislava
vaccines
Prior art date
Application number
BRPI0516253-0A
Other languages
English (en)
Inventor
Thomas Jack Newby
Cassius Mcallister Tucker
Joseph Frantz
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35657262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0516253(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0516253A publication Critical patent/BRPI0516253A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

VACINAS CANINAS MULTIVALENTES CONTRA LEPTOSPIRA BRATISLAVA E OUTROS PATóGENOS. A invenção relaciona-se a vacinas e métodos para proteção de cachorros contra doença causada por Leptospira bratislava. Esta invenção também se relaciona a combinação de vacinas e métodos para proteger cachorros contra doença ou desordem causada por patógenos, por exemplo, infecções traqueobronquites cansadas por Bordetella bronchiseptica, cinomose canina causada por vírus da cinomose canina (CC), infecção de hepatite canina (IHC) causada por adenovírus canino do tipo 1 (ACT-1), doença respiratória causada por adenovírus canino tipo 2 (ACT-2), parainfluenza canina causada por vírus parainfluenza canina (PIC), enterite causada por coronavírus canino (CVC) e parvovírus canino (PVC), e leptospirose causada por Leptospira bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrahagiae ou Leptospira pomona.
BRPI0516253-0A 2004-10-06 2005-09-23 vacinas caninas multivalentes contra leptospira bratislava e outros patógenos BRPI0516253A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/959,757 US20050089533A1 (en) 2003-01-29 2004-10-06 Canine vaccines against Bordetella bronchiseptica
PCT/IB2005/003111 WO2006038115A1 (en) 2004-10-06 2005-09-23 Multivalent canine vaccines against leptospira bratislava and other pathogens

Publications (1)

Publication Number Publication Date
BRPI0516253A true BRPI0516253A (pt) 2008-08-26

Family

ID=35657262

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516253-0A BRPI0516253A (pt) 2004-10-06 2005-09-23 vacinas caninas multivalentes contra leptospira bratislava e outros patógenos

Country Status (26)

Country Link
US (2) US20050089533A1 (pt)
EP (1) EP1799253B1 (pt)
JP (2) JP4163245B2 (pt)
KR (3) KR101226869B1 (pt)
CN (2) CN101035558B (pt)
AT (1) ATE524193T1 (pt)
AU (1) AU2005290921C1 (pt)
BR (1) BRPI0516253A (pt)
CA (1) CA2583689C (pt)
CY (1) CY1114897T1 (pt)
DK (1) DK1799253T3 (pt)
ES (1) ES2370750T3 (pt)
FR (2) FR14C0078I1 (pt)
LU (2) LU92135I2 (pt)
ME (1) ME01306B (pt)
MX (1) MX2007004133A (pt)
NO (1) NO20071385L (pt)
NZ (3) NZ576898A (pt)
PL (1) PL1799253T3 (pt)
PT (1) PT1799253E (pt)
RS (1) RS52035B (pt)
RU (1) RU2400248C2 (pt)
SI (1) SI1799253T1 (pt)
UA (1) UA91197C2 (pt)
WO (1) WO2006038115A1 (pt)
ZA (1) ZA200702166B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
ME00485B (me) * 2005-10-07 2011-10-10 Zoetis Services Llc VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
JPWO2008032796A1 (ja) * 2006-09-13 2010-01-28 日本全薬工業株式会社 新規イヌ用ワクチン
UA99719C2 (ru) * 2006-11-03 2012-09-25 Шеринг-Плау Лтд. Вакцина для собак против болезни лайма
AU2015255165A1 (en) * 2006-12-27 2015-11-26 Zoetis Services Llc Methods of vaccine administration
CA2674026C (en) * 2006-12-27 2018-08-21 Pfizer Products Inc. Methods of vaccine administration
ES2389121T3 (es) 2007-02-27 2012-10-23 Wyeth Llc Composiciones inmunogénicas para el tratamiento y prevención de infecciones en animales
US7878586B2 (en) * 2007-10-29 2011-02-01 The Boeing Company System and method for an anticipatory passenger cabin
KR101254848B1 (ko) 2007-12-21 2013-04-15 화이자 인코포레이티드 열 처리된 박테린, 및 상기 열 처리된 박테린으로부터 제조된 에멀젼 백신
JP2013507925A (ja) 2009-10-14 2013-03-07 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ アライグマからのイヌパルボウイルス−２に関連するウイルスの分離
JP5865839B2 (ja) 2010-09-28 2016-02-17 共立製薬株式会社 粘膜アジュバント組成物
PL2670432T3 (pl) * 2011-02-04 2021-10-11 Zoetis Services Llc Kompozycje immunogenne Bordetella bronchiseptica
CA2826058C (en) * 2011-02-04 2017-06-06 Zoetis Llc Compositions for canine respiratory disease complex
CN102343088B (zh) * 2011-10-14 2013-02-13 浙江诺倍威生物技术有限公司 一种犬传染性气管支气管炎二联活疫苗及其制备方法
BR112015003074A2 (pt) 2012-08-17 2017-07-04 Intervet Int Bv composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
CN104582719B (zh) * 2012-08-17 2017-09-15 英特维特国际股份有限公司 灭活钩端螺旋体细菌的免疫原性组合物
US9314519B2 (en) * 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CZ307883B6 (cs) * 2013-01-29 2019-07-24 Bioveta, A.S. Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
KR101622554B1 (ko) 2014-07-16 2016-05-19 (주)양성그린바이오 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법
EP3909971A1 (en) 2020-09-28 2021-11-17 Institute of Life Sciences (ILS) Whole cell livestock vaccine for respiratory diseases
CN117187118B (zh) * 2023-08-16 2024-07-23 华中农业大学 一株支气管败血波氏杆菌a1218及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
RU2030915C1 (ru) * 1990-10-31 1995-03-20 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Вакцина против лептоспироза животных
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
CA2158540A1 (en) * 1993-03-31 1994-10-13 The Regents Of The University Of California Cloned leptospira outer membrane protein
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
AUPO549497A0 (en) * 1997-03-07 1997-03-27 Agriculture Victoria Services Pty Ltd Novel bacterial pathogens
US6306623B1 (en) * 1998-02-24 2001-10-23 The University Of California Leptospiral major outer membrane protein LipL32
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
US20020058039A1 (en) * 2000-04-27 2002-05-16 Coyne Michael J. Method of measuring the duration of adequate immune memory in companion animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
DE60222812T2 (de) * 2002-05-17 2008-08-28 Fundação Oswaldo Cruz (Fiocruz) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
RS20050177A (sr) * 2002-08-26 2007-06-04 Pfizer Products Inc., Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
MXPA05008051A (es) * 2003-01-29 2005-09-21 Pfizer Prod Inc Vacunas caninas contra bordetella bronchiseptica.
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
CA2674026C (en) * 2006-12-27 2018-08-21 Pfizer Products Inc. Methods of vaccine administration

Also Published As

Publication number Publication date
FR14C0079I1 (fr) 2014-12-19
PT1799253E (pt) 2011-11-10
AU2005290921B2 (en) 2010-07-08
AU2005290921C1 (en) 2012-10-11
LU92136I9 (pt) 2019-01-04
CN101035558A (zh) 2007-09-12
MX2007004133A (es) 2007-06-15
HK1112839A1 (en) 2008-09-19
SI1799253T1 (sl) 2011-11-30
JP2008239627A (ja) 2008-10-09
FR14C0078I1 (fr) 2014-12-19
NZ553867A (en) 2010-10-29
CN101035558B (zh) 2011-04-06
LU92135I2 (fr) 2013-03-18
NZ576898A (en) 2011-03-31
KR20120031294A (ko) 2012-04-02
PL1799253T3 (pl) 2012-01-31
ZA200702166B (en) 2008-11-26
EP1799253A1 (en) 2007-06-27
DK1799253T3 (da) 2011-11-28
US20050089533A1 (en) 2005-04-28
EP1799253B1 (en) 2011-09-14
WO2006038115A1 (en) 2006-04-13
JP4163245B2 (ja) 2008-10-08
LU92136I2 (fr) 2013-03-18
ES2370750T3 (es) 2011-12-22
KR20080096610A (ko) 2008-10-30
CA2583689A1 (en) 2006-04-13
CN101791398A (zh) 2010-08-04
KR101226869B1 (ko) 2013-01-25
US20080175860A1 (en) 2008-07-24
RU2400248C2 (ru) 2010-09-27
ME01306B (me) 2013-12-20
RS52035B (sr) 2012-04-30
RU2007112480A (ru) 2008-11-20
LU92135I9 (pt) 2019-01-04
JP2008515873A (ja) 2008-05-15
ATE524193T1 (de) 2011-09-15
KR20070050499A (ko) 2007-05-15
NZ591422A (en) 2012-09-28
AU2005290921A1 (en) 2006-04-13
CY1114897T1 (el) 2016-12-14
CA2583689C (en) 2013-06-11
NO20071385L (no) 2007-04-18
UA91197C2 (ru) 2010-07-12

Similar Documents

Publication Publication Date Title
BRPI0516253A (pt) vacinas caninas multivalentes contra leptospira bratislava e outros patógenos
BRPI0407032A (pt) Vacinas caninas contra bordetella bronchiseptica
AR064530A1 (es) Procedimientos para la administracion de vacunas
PE20040420A1 (es) Vacunas para enfermedades reproductivas del ganado
AR069216A1 (es) Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos
ATE481080T1 (de) Verfahren und mittel zur infiltration von zahnschmelz-läsionen
AR043892A1 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BRPI0407436A (pt) Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca
AR070675A1 (es) Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente
UA110505C2 (ru) Імуногенні композиції bordetella bronchiseptica
RU2013135887A (ru) Композиции для комплекса респираторных заболеваний собак
WO2008106393A3 (en) Immunogenic compositions and methods for treating and preventing animal infections
BR112014029725A2 (pt) vacinação com coronavírus respiratório canino para proteção contra infecções por b. bronchiseptica
DK2050463T3 (da) Vaccinesammensætning til vaccination af hunde mod hundeinfektiøs respiratorisk sygdom (CIRD)
MY153290A (en) Multivalent avian influenza vaccines
RU2012143152A (ru) Способ защиты от заболеваний, вызываемых вторичными патогенами
AR067322A1 (es) Vector poxvirus recombinante de mapache (rrcnv) vacuna felina, plasmido y metodos para inducir una respuesta inmune protectora a un patogeno de felino en un gato
TH71070A (th) วัคซีนสุนัขต้าน Bordetella bronchiseptica
RU2025100978A (ru) Вакцина для защиты против leptospira серовара icterohaemorrhagiae
FR2794648B1 (fr) Vaccins adn pour animaux de compagnie et de sport
Casal How have vaccines changed the incidence of infectious diseases?
UA32966U (ru) Вакцина против лептоспироза животных поливалентная (вариант suis)
BR102012021810A2 (pt) Xantana como adjuvante em vacina de subunidade recombinante

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH USA 15 LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS P LLC (US)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 25, 10 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.